Breast Cancer Adjuvant Therapy: Time to Consider Its Time-Dependent Effects

This publication has 28 references indexed in Scilit:

• Improved Endpoints for Cancer Immunotherapy Trials
  JNCI Journal of the National Cancer Institute, 2010
• Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions
  Cancer Causes & Control, 2008
• Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?
  Nature Reviews Cancer, 2007
• Concordance among Gene-Expression–Based Predictors for Breast Cancer
  New England Journal of Medicine, 2006
• Effects of Estrogen Receptor Expression and Histopathology on Annual Hazard Rates of Death from Breast Cancer
  Breast Cancer Research and Treatment, 2006
• Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer
  JAMA, 2006
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
  The Lancet, 2005
• Hazard rates of recurrence following diagnosis of primary breast cancer
  Breast Cancer Research and Treatment, 2005
• A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
  New England Journal of Medicine, 2004
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958